PET/X LLC, spun out of the University of Washington, develops imaging systems that guide the best selection of cancer therapy. The firm's name comes from PET (positron emmision tomography) and X-ray mammography to quickly and reliably determine which targeted breast cancer therapies will be effective for each patient.
